Brain Tumor Interface Analysis Reveals Metastatic Hotspots in Meningiomas

Meningiomas are common brain tumors that frequently recur and metastasize, particularly at the boundary where tumor meets healthy brain tissue. Understanding this critical interface could improve treatment outcomes, but previous research has been limited by the difficulty of precisely sampling these boundary regions.

Researchers analyzed single-cell RNA sequencing data from 33 samples across 23 patients, including normal brain tissue, brain-tumor interfaces (BTI), and tumor cores. They used advanced computational methods to identify distinct cell populations and their molecular signatures at different locations within and around meningiomas.

The analysis revealed that the BTI contains a unique population of tumor cells with enhanced invasion capabilities, characterized by epithelial-mesenchymal transition (EMT) features that promote metastasis. These invasive cells were marked by high expression of ANXA2 and COL5A1 proteins. Additionally, the BTI harbored an immunosuppressive microenvironment dominated by SPP1+ tumor-associated macrophages, along with specific endothelial cells and pericytes that promote aggressive tumor growth and blood vessel formation.

These findings suggest that the brain-tumor interface serves as a specialized metastatic niche where tumors acquire invasive properties while evading immune surveillance. The identified biomarkers could potentially be used to detect early signs of tumor spread and recurrence, enabling more targeted treatment approaches. This research provides crucial insights into why meningiomas tend to recur at surgical margins and offers new targets for therapeutic intervention.